Journal of Medicinal Chemistry · 2014 · 26 citations · 23 references
PharmacyMedicinal ChemistryOrthopaedic SurgeryDrug DesignDrug DiscoveryLead OptimizationCartilage BreakdownCartilage DegenerationCartilage MetabolismJoint DiseaseOsteoarthritisOsteoarthritis ManagementAggrecan BiologyExperimental Surgical ModelsProtease Inhibitors In CartilageSelectivityZinc Enzymes
A disintegrin and metalloproteinase with thrombospondin motifs-4 (ADAMTS-4) and ADAMTS-5 are zinc metalloproteases commonly referred to as aggrecanase-1 and aggrecanase-2, respectively. These enzymes are involved in the degradation of aggrecan, a key component of cartilage. Inhibitors of these enzymes could be potential osteoarthritis (OA) therapies. A series of hydantoin inhibitors of ADAMTS-4 and ADAMTS-5 were identified from a screening campaign and optimized through structure-based drug design to give hydantoin 13. Hydantoin 13 had excellent selectivity over other zinc metalloproteases such as TACE, MMP2, MMP3, MMP13, and MMP14. The compound also produced efficacy in both a chemically induced and surgical model of OA in rats.
23
Burden of major musculoskeletal conditions.
Anthony D. Woolf, Bruce Pfleger · PubMed · 2003 · 3.5K citations
Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis
S.S. Glasson, Roger Askew, Barbara Sheppard et al. · Nature · 2005 · 1.3K citations